Arcus Biosciences (RCUS) Interest Coverage Ratio (2023 - 2026)
Arcus Biosciences (RCUS) recorded quarterly Interest Coverage Ratio of 44.67 in Q1 2026, up 21.64% quarter-over-quarter from 57.0 in Q4 2025, and up 63.39% on a YoY basis from 27.34 in Q1 2025.
Arcus Biosciences (RCUS) Interest Coverage Ratio (2023 - 2026) Analysis & Trends
Arcus Biosciences' Interest Coverage Ratio history runs 4 years deep, the most recent figure standing at 44.67 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 63.39% year-over-year to 44.67; the TTM figure through Mar 2026 stood at 39.8 (up 63.49% YoY), while the FY2025 annual figure was 48.25, up 41.52% from the prior year.
- Interest Coverage Ratio was 44.67 for Q1 2026 at Arcus Biosciences, up from 57.0 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 4.0 in Q2 2025 to a low of 122.0 in Q1 2025.
- Historically, Interest Coverage Ratio has averaged 58.61 across 4 years, with a median of 51.5 in 2024.
- The sharpest annual moves came in 2025 and 2026: Interest Coverage Ratio tumbled 662.5% in 2025, then soared 63.39% in 2026.
- A 4-year view of Interest Coverage Ratio shows it stood at 80.0 in 2023, then jumped by 35.62% to 51.5 in 2024, then declined by 10.68% to 57.0 in 2025, then grew by 21.64% to 44.67 in 2026.
- The last three Interest Coverage Ratio figures came in at 44.67 (Q1 2026), 57.0 (Q4 2025), and 47.33 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Arcus Biosciences | 3.05 Bn | 2.23 Bn | - | -44.67 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.67 |
| Dec 31, 2025 | -57.00 |
| Sep 30, 2025 | -47.33 |
| Jun 30, 2025 | -4.00 |
| Mar 31, 2025 | -122.00 |
| Dec 31, 2024 | -51.50 |
| Sep 30, 2024 | -105.00 |
| Mar 31, 2024 | -16.00 |
| Sep 30, 2023 | -80.00 |